CIENCIASMEDICASNEWS: FDA approves first generic of Proventil HFA (albuterol sulfate)

viernes, 10 de abril de 2020

FDA approves first generic of Proventil HFA (albuterol sulfate) - Drug Information Update

https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-commonly-used-albuterol-inhaler-treat-and-prevent-bronchospasm?utm_campaign=FDA%20approves%20first%20generic%20of%20Proventil%20HFA%20%28albuterol%20sulfate%29&utm_medium=email&utm_source=Eloqua
DDI Listserv Header Capsule

FDA approves first generic of Proventil HFA (albuterol sulfate) Metered Dose Inhaler

The U.S. Food and Drug Administration today approved the first generic of Proventil HFA (albuterol sulfate) Metered Dose Inhaler, 90 mcg/Inhalation, for the treatment or prevention of bronchospasm in patients four years of age and older who have reversible obstructive airway disease, as well as the prevention of exercise-induced bronchospasm in this age group.

The most common side effects associated with Albuterol Sulfate Metered Dose Inhaler, 90 mcg/Inhalation, are upper respiratory tract infection, rhinitis, nausea, vomiting, rapid heart rate (tachycardia), tremor and nervousness.